Softwr

Healthcare · head to head

DHIS2 vs Rx30

DHIS2 logo

DHIS2

Healthcare

Open source health information platform run from the University of Oslo and used by national ministries

From
Free
Rated
-
Full reviewWebsite
Rx30 logo

Rx30

Healthcare

Long-established pharmacy management system for independents and small chains

From
On request
Rated
-
Full reviewWebsite

The short version

  • Only DHIS2 has a free tier, so it costs nothing to try first.
  • Each has a real cost: DHIS2 the licence is free and the implementation is not; national rollouts routinely cost hundreds of thousands of dollars in configuration, hosting, training and support, and budgets built on the word free fail immediately.; Rx30 shares ownership with PioneerRx, so the two are not the independent alternatives a shortlist implies, and roadmap priorities are set centrally
  • They diverge on capability: DHIS2 covers Aggregate data reporting, Rx30 covers Prescription processing.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which DHIS2 and Rx30 actually diverge.

Attributes where DHIS2 and Rx30 differ
AttributeDHIS2Rx30
Starting priceFreeOn request
Pricing modelOpen source, no licence feequote
Free tierYesNo
PlatformsWeb, Android, Self-hosted, CloudWindows, Web

Identical on both: user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in DHIS2

  • Aggregate data reporting
  • Tracker
  • Android capture app
  • Dashboards and analytics
  • Metadata packages
  • Data quality tools
  • GIS mapping
  • Interoperability

Only in Rx30

  • Prescription processing
  • Claims adjudication
  • Inventory and purchasing
  • Point of sale
  • Delivery management
  • Clinical documentation

What people use each for

The jobs each tool is most often brought in to do.

DHIS2

  • A ministry of health replacing paper monthly reporting from thousands of facilities with a national routine systemnot Rx30
  • A donor-funded HIV or tuberculosis programme that must report standard indicators across several districtsnot Rx30
  • A disease surveillance unit needing weekly case reporting with outbreak alerting and mappingnot Rx30
  • An NGO running individual patient follow-up in a programme where facilities are frequently offlinenot Rx30

Rx30

  • Independent pharmacies and small chains wanting a mature, widely-supported systemnot DHIS2
  • Operations relying on a broad set of wholesaler and PBM interfacesnot DHIS2
  • Pharmacies with significant front-end retail alongside dispensingnot DHIS2
  • Multi-store independents needing consistency across locationsnot DHIS2

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

DHIS2

  • The licence is free and the implementation is not; national rollouts routinely cost hundreds of thousands of dollars in configuration, hosting, training and support, and budgets built on the word free fail immediately.
  • HISP UiO introduced a Shared Services Fee in 2025, so organisations that depend on DHIS2 are now being asked for an annual contribution that did not previously exist in their plans.
  • Development funding comes from a small set of donors including Norad, the Global Fund and the Gates Foundation, which concentrates the platform's long-term direction in the priorities of those funders.
  • Implementation capability is concentrated in regional HISP groups, so a country whose local HISP group is overstretched has few alternative suppliers with equivalent expertise.
  • Analytics performance depends heavily on how metadata was designed at the outset, and a poorly structured initial configuration produces slow dashboards and bad indicator definitions that are painful to correct years later.

Rx30

  • Shares ownership with PioneerRx, so the two are not the independent alternatives a shortlist implies, and roadmap priorities are set centrally
  • The interface shows its age against newer entrants, and this is the most common objection in demonstrations
  • Pricing is not published, and total cost including hardware and interfaces needs to be requested explicitly
  • Windows-centric, with a cloud story less developed than newer competitors
  • US-only, tied to US insurance and regulatory requirements

Pricing, plan by plan

DHIS2

Free
  • DHIS2 softwareFree
    • BSD licence
    • All modules including Tracker
    • No user or facility limits
  • Shared Services Fee$undefined/year
    • Voluntary annual contribution introduced by HISP UiO
    • Funds shared global infrastructure and platform sustainability
    • Amount agreed with the HISP Centre
  • Implementation and support$undefined/year
    • Delivered by regional HISP groups or private implementers
    • Configuration, metadata design, hosting, training and support
    • Quoted per programme, commonly the dominant cost

Rx30

On request
  • Rx30$undefined/month
    • Prescription processing
    • Claims adjudication
    • Inventory

Which should you pick?

Choose DHIS2 if

  • You need aggregate data reporting.
  • You want to start without paying.
  • You work on Web, Android, Self-hosted, Cloud.
  • You also want tracker.
DHIS2 review

Choose Rx30 if

  • You need prescription processing.
  • You work on Windows, Web.
  • You also want claims adjudication.
Rx30 review

Questions people ask

Is DHIS2 or Rx30 better?
Neither clearly leads. DHIS2 starts at Free and Rx30 at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, DHIS2 or Rx30?
DHIS2 has a free tier; the other does not. Paid plans start at Free for DHIS2 and On request for Rx30.
Does DHIS2 or Rx30 run on more platforms?
DHIS2 runs on Web, Android, Self-hosted, Cloud. Rx30 runs on Windows, Web.
Can I use DHIS2 for free?
Yes. DHIS2 has a free tier, so you can try it without paying. Rx30 starts at On request.
What is DHIS2 best used for?
DHIS2 is most often used for a ministry of health replacing paper monthly reporting from thousands of facilities with a national routine system, a donor-funded hiv or tuberculosis programme that must report standard indicators across several districts, a disease surveillance unit needing weekly case reporting with outbreak alerting and mapping, an ngo running individual patient follow-up in a programme where facilities are frequently offline. Of those, a ministry of health replacing paper monthly reporting from thousands of facilities with a national routine system and a donor-funded hiv or tuberculosis programme that must report standard indicators across several districts are not what Rx30 is typically brought in for.
What can DHIS2 do that Rx30 cannot?
DHIS2 covers Aggregate data reporting, Tracker, Android capture app, Dashboards and analytics. Rx30 covers Prescription processing, Claims adjudication, Inventory and purchasing, Point of sale.

Answered from the vendors’ own pages

DHIS2: Who owns and develops DHIS2?

The HISP Centre at the University of Oslo, funded by donors including Norad, the Global Fund, the Gates Foundation and Wellcome.

Rx30: Is Rx30 the same company as PioneerRx?

Both are owned by RedSail Technologies. They are sold as separate products to overlapping markets, but roadmap decisions sit with one company, which is worth knowing before treating them as independent options.

DHIS2: Is DHIS2 free?

The software is free under a BSD licence. Implementation, hosting, training and support are not, and are the dominant cost.

Rx30: What does it cost?

Not published. Request the total including hardware, interfaces and training rather than the monthly software fee.

DHIS2: What is the Shared Services Fee?

A voluntary annual contribution introduced by HISP UiO in 2025 to fund shared global infrastructure and long-term platform sustainability.

Rx30: Why do pharmacies stay on it?

Installed base maturity. The interfaces to wholesalers, PBMs and hardware are long established, and those are the things that quietly stop a pharmacy working when they break.

DHIS2: Can I buy commercial support?

Yes, from regional HISP groups or private implementers such as Devotta, which is contracted by HISP UiO for core platform development and also works independently.

Rx30: How does it compare to PioneerRx?

PioneerRx is more aggressively developed around clinical services. Rx30 has the larger legacy base and broader front-end retail heritage. Same owner, different emphasis.

Rx30: Is it suitable for a small chain?

Yes, and that is one of its stronger cases. Multi-store consistency is better handled here than by the systems aimed purely at single independents.

Share

Related pages

More on DHIS2

More on Rx30

Keep looking

Other head to heads